The Cigna Group CI
Set alert
295.19 USD -3.04 -1.02%
At close · Nov 2
294.70 -0.49 -0.17%
After hours · Nov 2, 6:46 PM ET
291.93 Day range 300.50
244.41 52-week range 315.88
- YTD
- +7.25%
- 1 year
- +20.78%
- Open
- 300.47
- Prev close
- 298.23
- Mkt cap
- 78.00B
- Vol
- 1.51M
- Avg vol
- 1.61M
- EPS
- 24.19
- P/E
- 12.20
- Div yield
- 2.09%
More statistics
- Low
- 291.93
- High
- 300.50
- Forward P/E
- 8.82
- Beta
- 0.25
- Short ratio
- 4.15
- Inst. own
- 92.33%
- Dividend
- 6.24
- Ex-div date
- Dec 2, 2026
- Earnings
- Nov 5, 2026
- 50-d avg
- 283.91
- 200-d avg
- 281.65
- 1y target
- 342.29
5Y chart
Events in this range
- Dec 6, 2021Dividend: 1
- Mar 8, 2022Dividend: 1.12
- Jun 7, 2022Dividend: 1.12
- Sep 6, 2022Dividend: 1.12
- Dec 5, 2022Dividend: 1.12
- Dec 21, 2022Dividend: 1.12
- Mar 7, 2023Dividend: 1.23
- Jun 6, 2023Dividend: 1.23
- Sep 5, 2023Dividend: 1.23
- Dec 5, 2023Dividend: 1.23
- Mar 5, 2024Dividend: 1.4
- Mar 6, 2024Dividend: 1.4
- Jun 4, 2024Dividend: 1.4
- Sep 4, 2024Dividend: 1.4
- Dec 4, 2024Dividend: 1.4
- Mar 5, 2025Dividend: 1.51
- Jun 3, 2025Dividend: 1.51
- Jul 31, 2025Earnings: 7.2; estimate 7.16; surprise 0.56%
- Sep 4, 2025Dividend: 1.51
- Oct 30, 2025Earnings: 7.83; estimate 7.64; surprise 2.49%
- Dec 4, 2025Dividend: 1.51
- Feb 5, 2026Earnings: 8.08; estimate 7.88; surprise 2.54%
- Mar 5, 2026Dividend: 1.56
- Apr 30, 2026Earnings: 7.79; estimate 7.6; surprise 2.5%
- Jun 4, 2026Dividend: 1.56
- Jul 30, 2026Earnings: 7.78; estimate 7.6; surprise 2.37%
- Jul 31, 2026Rating: Guggenheim · Buy → Buy
- Jul 31, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- Aug 3, 2026Downgrade: Raymond James · Strong Buy → Outperform
- Aug 4, 2026Downgrade: Jefferies · Buy → Hold
- Sep 8, 2026Dividend: 1.56
- Oct 1, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 2, 2026Rating: Piper Sandler · Overweight → Overweight
- Nov 5, 2026Earnings: —; estimate 7.52; surprise —%
Signals (102)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | May 25, 2026 | 5 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
Newest 20 of 102.
Analyst view
Consensus: buy
Buy
Price target (mean) 342.29 +16.0% upside
Now 295.19
- Target (low)
- 288.00
- Target (mean)
- 342.29
- Target (high)
- 400.00
Ratings (0m) 24 17 buy · 7 hold · 0 sell
- Strong buy5
- Buy12
- Hold7
- Sell0
- Strong sell0
Recommendation trend
- This month 24
- 1 month ago 24
- 2 months ago 24
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 7.51 | 7.42 – 7.71 | 7.83 | -4.1% | 72.45B | +3.9% | 23 |
| Next quarter | 7.42 | 7.22 – 7.63 | 8.08 | -8.1% | 74.58B | +2.9% | 22 |
| Current year | 30.51 | 30.44 – 30.71 | 29.84 | +2.2% | 287.45B | +4.6% | 24 |
| Next year | 33.49 | 32.76 – 33.84 | 30.51 | +9.8% | 299.16B | +4.1% | 24 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 2, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 1, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 4, 2026 | Jefferies | Downgrade | Buy | Hold |
| Aug 3, 2026 | Raymond James | Downgrade | Strong Buy | Outperform |
| Jul 31, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 31, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 31, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 9, 2026 | Bernstein | Maintained | Outperform | Outperform |
| Jun 8, 2026 | Mizuho | Maintained | Outperform | Outperform |
| May 26, 2026 | Barclays | Downgrade | Overweight | Equal-Weight |
| May 22, 2026 | UBS | Maintained | Buy | Buy |
| May 20, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 20, 2026 | Deutsche Bank | Downgrade | Buy | Hold |
| May 5, 2026 | Bernstein | Maintained | Outperform | Outperform |
| May 4, 2026 | Guggenheim | Maintained | Buy | Buy |
| May 1, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 1, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| May 1, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 1, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Apr 20, 2026 | Jefferies | Maintained | Buy | Buy |
| Mar 12, 2026 | Bernstein | Upgrade | Market Perform | Outperform |
| Mar 3, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Feb 17, 2026 | Truist Securities | Reiterated | Buy | Buy |
| Feb 9, 2026 | TD Cowen | Maintained | Buy | Buy |
| Feb 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 6, 2026 | Guggenheim | Maintained | Buy | Buy |
| Feb 2, 2026 | Guggenheim | Reiterated | Buy | Buy |
| Jan 5, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jan 5, 2026 | Barclays | Maintained | Overweight | Overweight |